
Proteomic organ-specific aging clocks have shown promise in quantifying age-related risks, yet their generalizability to non-European populations and their biological underpinnings remain poorly characterized. This study evaluated organismal and 11 organ-specific clocks based on SomaScan v5.0 proteomics in 185 Chinese adults from the Hong Kong Osteoporosis Study enriched for high and low bone mineral density. Over a median follow-up of 20.3 years, muscle aging was associated with incident chronic kidney disease after FDR correction (HR per SD increase=2.84, 95% CI = 1.51–5.34). Several additional organ-concordant associations were observed at nominal significance (P < 0.05) and consistent with prior literature, including heart aging with ischemic heart disease (HR = 1.50, 95% CI = 1.00–2.25), adipose aging with diabetes (HR = 1.56, 1.05–2.31), and lung aging with chronic obstructive pulmonary disease (HR = 3.77, 1.33–10.69). Immune (HR = 1.95) and brain aging (HR = 1.73) were also associated with all-cause mortality after FDR correction. Notably, individuals with ≥3 vs. no aged organs had a 16.5-fold higher mortality risk (95% CI = 5.34–50.78). Metabolome-wide analyses identified 380 metabolites associated with ≥1 organ age gap at FDR < 0.05, with taurine-hypotaurine metabolism pathway enriched across multiple organs. Mendelian randomization analysis further identified four statistically significant associations, including an inverse association of genetically predicted hypotaurine with brain aging. These findings provide supportive evidence for the applicability of organ-specific proteomic clocks in this Chinese cohort and implicate taurine-hypotaurine metabolism in the proteomic signatures of multi-organ aging.
Vascular aging (VA) is the pathological basis of cardiovascular diseases, but its molecular mechanisms are unclear. Analyzing 2920 proteins in 42,326 participants, we identified 44 VA-associated proteins via logistic regression with prespecified age/sex stratification. An internally cross-validated machine-learning model integrating these proteins with the Framingham Risk Score (FRS) improved VA classification (AUC 0.911), reclassifying 14.8% of individuals beyond FRS. Risk tertiles showed distinct survival curves across six vascular diseases over 15 years. Mendelian randomization prioritized 11 of the 44 proteins in relation to arterial stiffness index; nine were differentially expressed in human serum or aged mouse arterial tissues. Using VA-related cynomolgus arterial single-cell RNA-seq, six of these nine showed cell-type–specific expression changes in endothelial cells and pericytes. In these cell types, knockdown of IGFBP2 and LAYN aggravated senescence-related phenotypes, whereas that of FAM20A, ERBB2, and SMAD5 attenuated them under the conditions examined. Our findings characterize circulating proteomic alterations associated with VA and identify candidates for future biomarker and mechanistic studies.
Aging is characterized by chronic low-grade inflammation, to which overactivation of the brain angiotensin II (Ang II)/AT1 receptor (AT1R) axis significantly contributes. Milk fat globule–EGF factor 8 (MFG-E8, lactadherin) promotes microglial efferocytosis and resolution of inflammation, but its interaction with AT1R signaling, particularly in the aging brain, remains unclear. We identify a bidirectional regulatory loop between Ang II/AT1R and MFG-E8/αvβ3 integrin pathways using neuronal–glial models and young and aged human and mouse brain tissue. Ang II/AT1R activation reduced MFG-E8 expression and impaired clearance of apoptotic neurons. Conversely, apoptotic signals and recombinant MFG-E8 suppressed AT1R expression and inflammatory signaling while enhancing pro-resolving pathways, involving NF-κB and STAT3 modulation. Aged brain tissue showed AT1R overactivation associated with reduced MFG-E8 expression. These findings reveal a previously unrecognized feedback interaction that limits resolution of neuroinflammation during aging, identifying the Ang II–MFG-E8 axis as a potential therapeutic target.
Parkinson’s disease begins years before motor symptoms appear. Longitudinal blood transcriptomics shows that DNA repair and stress response pathways are most altered during this prodromal phase, then lose discriminative power in established disease. In this Comment, we link these changes to aging-related DNA damage and consider their biomarker potential. Mirroring aging hallmarks, they suggest a prodromal intervention window, when mechanisms driving dopaminergic neuron vulnerability are most active and potentially tractable.
Immobilization is a major cause of muscle atrophy in older adults, particularly in critically ill patients. Irisin is an exercise-induced myokine that supports muscle homeostasis, but its therapeutic potential for immobilization-induced muscle atrophy in older adults remains unclear. By measuring plasma irisin in respiratory care unit (RCU) patients and community-dwelling older adults, we found that RCU patients who were bedridden for ≥7 days had lower plasma irisin levels than community-dwelling older adults, and lower irisin levels were associated with a higher risk of thrombocytopenia. In aged immobilized mice, lipid nanoparticle (LNP)-encapsulated irisin circular RNA (circRNA) restored muscle weight and myofiber size and increased PAX7 immunostaining. Transcriptomic analysis identified suppression of FOXO1 and its downstream genes associated with cell-cycle arrest as a predicted mechanism promoting muscle regeneration. Collectively, these findings demonstrate LNP-encapsulated irisin circRNA as a potential therapeutic approach for immobilization-induced muscle atrophy in aging.